drugset / Trial / NCT00648999
Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To demonstrate that patients treated with Kaletra have an improvement in their quality of life compared to the quality of life they had with their previous NRTI therapy.
Timeline
- Start
- 2003-11
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lopinavir | Other / unclassified | 400 mg | — |
| Comparator | Ritonavir | Other / unclassified | 100 mg | — |